Business Description
Alpha Cognition Inc
NAICS : 541710
SIC : 3741
ISIN : CA02074J2048
Share Class Description:
ACOG: Ordinary SharesTotal Employee Number:
71Description
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.82 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 8.42 | |||||
Beneish M-Score | 3.58 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 33.6 | |||||
3-Year EPS without NRI Growth Rate | 38.4 | |||||
3-Year FCF Growth Rate | 30 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 102.69 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 78.11 | |||||
9-Day RSI | 69.76 | |||||
14-Day RSI | 66.3 | |||||
3-1 Month Momentum % | 35.57 | |||||
6-1 Month Momentum % | 34.87 | |||||
12-1 Month Momentum % | -4.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 9.03 | |||||
Quick Ratio | 8.04 | |||||
Cash Ratio | 6.45 | |||||
Days Inventory | 1085.16 | |||||
Days Sales Outstanding | 85.86 | |||||
Days Payable | 344.47 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 89.89 | |||||
Operating Margin % | -190.55 | |||||
Net Margin % | -153.61 | |||||
EBITDA Margin % | -189.31 | |||||
FCF Margin % | -242.98 | |||||
OCF Margin % | -202.17 | |||||
ROE % | -49.09 | |||||
ROA % | -38.44 | |||||
ROIC % | -376.9 | |||||
3-Year ROIIC % | -391.83 | |||||
ROC (Joel Greenblatt) % | -501.57 | |||||
ROCE % | -53.05 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 23.25 | |||||
PS Ratio | 13.23 | |||||
PB Ratio | 4.01 | |||||
Price-to-Tangible-Book | 4.52 | |||||
EV-to-EBIT | -5.66 | |||||
EV-to-EBITDA | -5.7 | |||||
EV-to-Revenue | 10.79 | |||||
EV-to-Forward-Revenue | 6.13 | |||||
EV-to-FCF | -4.44 | |||||
| Price-to-Net-Current-Asset-Value | 4.56 | |||||
| Price-to-Net-Cash | 7.09 | |||||
Earnings Yield (Greenblatt) % | -17.67 | |||||
FCF Yield % | -17.46 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ACOG
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alpha Cognition Inc Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 15.261 | ||
| EPS (TTM) ($) | -1.34 | ||
| Beta | 1.2158 | ||
| 3-Year Sharpe Ratio | 0.11 | ||
| 3-Year Sortino Ratio | 0.19 | ||
| Volatility % | 52.43 | ||
| 14-Day RSI | 66.3 | ||
| 14-Day ATR ($) | 0.741269 | ||
| 20-Day SMA ($) | 8.81025 | ||
| 12-1 Month Momentum % | -4.48 | ||
| 52-Week Range ($) | 4.5 - 10.1 | ||
| Shares Outstanding (Mil) | 21.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alpha Cognition Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alpha Cognition Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 16:30 | In 84 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 83 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-13 16:30 | 8.95 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-08-13 | 8.95 (+0.00%) | ||
| General meeting for 2026 | 2026-06-16 09:00 | 5.99 (-1.48%) | ||
| First quarter earnings conference call for 2026 | 2026-05-14 16:30 | 5.95 (+7.59%) | ||
| First quarter earnings results for 2026 | 2026-05-14 | 5.95 (+7.59%) | ||
| Annual report for 2026 | 2026-03-31 | 5.32 (+5.98%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-26 16:30 | 5.32 (-4.83%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-26 | 5.32 (-4.83%) |
Show
Entries
Alpha Cognition Inc Frequently Asked Questions
What is Alpha Cognition Inc(ACOG)'s stock price today?
The current price of ACOG is $9.72. The 52 week high of ACOG is $10.10 and 52 week low is $4.50.
When is next earnings date of Alpha Cognition Inc(ACOG)?
The next earnings date of Alpha Cognition Inc(ACOG) is 2026-11-13 Est..
Does Alpha Cognition Inc(ACOG) pay dividends? If so, how much?
Alpha Cognition Inc(ACOG) does not pay dividend.
Press Release
Articles on Alpha Cognition Inc
Headlines
See More- 1
Aug 20, 2026
Alpha Cognition rises as B. Riley initiates at Buy on Alzheimer’s drug
Seeking Alpha • 11:39am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers